Immunovant (IMVT) PT Raised to $57 at Stifel
Tweet
Share
E-mailGet Alerts IMVT Hot Sheet
Price: $37.29 --0%
Rating Summary:
16 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 30
Rating Summary:
16 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 30
Join SI Premium – FREE
Stifel analyst Alex Thompson raised the price target on Immunovant (NASDAQ: IMVT) to $57.00 (from $49.00) while maintaining a Buy rating.
You May Also Be Interested In
- Immunovant halts CLE development after IMVT-1402 trial misses goal
- Compass Therapeutics (CMPX) PT Lowered to $12 at H.C. Wainwright
- DGB Financial Group (139130:KS) PT Raised to KRW20,000 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
